← Leaderboards
Jonathan White
Midwest Research Institute
$29,583,809
Attributed
$29,583,809
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $7.8M · FY2010–23$10M$7.5M$5M$2.5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$29,583,809 · 7
By mechanism
N02$25,597,010 · 7
N01$3,986,799 · 2
Top collaborators
No co-investigators on record.
Most similar at Midwest Research Institute
Same institution · by research overlap
- Bruce Diel$11,591,089
- Gregory Turner$495,661
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsReportingMalignant NeoplasmsDrug FormulationsPharmacologic SubstanceUnited States Food And Drug AdministrationQuality ControlSamplingDosage FormsInvestigationResearch PersonnelLifeInvestigational New Drug ApplicationExpirationContractsContractorInvestigational DrugsNational Cancer InstituteQuality AssuranceAntitumor DrugClinical ResearchAntitumor AgentDrug CandidatePrograms
Grant awards (31)
Drug Shelf Life Testing$243,000
N02 · FY2023 · CA · contact PI
THE OBJECTIVE OF THIS TASK ORDER IS TO PERFORM DEVELOPMENTAL STUDIES OF ISOTOPE-SPECIFIC 2-KETOGLUTARIC ACID.$7,811
N02 · FY2023 · CA · contact PI
Drug Shelf Life Testing$222,142
N02 · FY2022 · CA · contact PI
STABILITY STUDIES OF ISOTOPE-SPECIFIC 2-KETOGLUTARIC ACID$48,980
N02 · FY2022 · CA · contact PI
Drug Shelf Life Testing$230,000
N02 · FY2021 · CA · contact PI
PERFORM DEVELOPMENTAL STUDIES OF ISOTOPE-SPECIFIC 2-KETOGLUTARIC ACID.$61,326
N02 · FY2021 · CA · contact PI
Drug Shelf Life Testing$450,000
N02 · FY2020 · CA · contact PI
Drug Shelf Life Testing$363,448
N02 · FY2019 · CA · contact PI
Task Order #1: Centralized Chemopreventive Agent Repository and Chemistry Support$3,758,949
N02 · FY2018 · CA · contact PI
Drug Shelf Life Testing$300,000
N02 · FY2018 · CA · contact PI
TO# 2018-02; NExT Z-Endoxifen CT025-402-448-004 - API Batch analysis Milestone 4, Analysis of Anti-Cancer Chemical & Pharmaceutical Formulations, HHSN261201700011I, DTP-18-022, 5/15 - 8/15/18,$7,307
N02 · FY2018 · CA · contact PI
NEXT Z-ENDOXIFEN CT025-402-448-004 - API BATCH ANALYSIS OF 1 CGMP LOT NSC 750393, ANALYSIS OF ANTI-CANCER CHEMICAL & PHARMACEUTICAL FORMULATIONS, HHSN261201700011I, DTP-18-011, 2/12/18 - 7/31/18, PRB$7,205
N02 · FY2018 · CA · contact PI
IGF::OT::IGF Centralized Chemopreventive Agent Repository and Drug Chemistry SupportPeriod of Performance 09/01/2011 - 03/28/2016.$4,744,035
N02 · FY2017 · CA · contact PI
IGF::OT::IGF Administrative Costs - Contract Orientation and Kick Off Meeting -Analysis of Anti-Cancer Chemical & Pharm Formulations , HHSN261201700011I, DTP-17-040, 8/01/2017 - 09/30/2017, PRB$1,236
N02 · FY2017 · CA · contact PI
CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND DRUG CHEMISTRY SUPPORT$4,103,458
N02 · FY2016 · CA · contact PI
IGF::OT::IGF Centralized Chemopreventive Agent Repository and Drug Chemistry SupportPeriod of Performance 09/01/2011 - 03/28/2016.$243,833
N02 · FY2016 · CA · contact PI
ANALYSIS OF ANTI-CANCER CHEMICALS & PHARMACEUTICAL FORMULATION$22,162
N02 · FY2016 · CA · contact PI
CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND DRUG CHEMISTRY SUPPORT$4,024,032
N02 · FY2015 · CA · contact PI
OTHER FUNCTIONS - ANALYSIS OF ANTI-CANCER CHEMICALS & PHARMACEUTICAL FORMULATION$38,857
N02 · FY2015 · CA · contact PI
CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND DRUG CHEMISTRY SUPPORT$3,945,977
N01 · FY2014 · CA · contact PI
IGF::OT::IGF Centralized Chemopreventive Agent Repository and Drug Chemistry SupportPeriod of Performance 09/01/2011 - 03/28/2016.$3,815,540
N02 · FY2014 · CA · contact PI
OTHER FUNCTIONS - ANALYSIS OF ANTI-CANCER CHEMICALS & PHARMACEUTICAL FORMULATION$40,822
N01 · FY2014 · CA · contact PI
OTHER FUNCTIONS - ANALYSIS OF ANTI-CANCER CHEMICALS & PHARMACEUTICAL FORMULATION$77,202
N02 · FY2013 · CA · contact PI
The Shelf Live Evaluation of Investigational Dosage Forms$30,000
N02 · FY2013 · CA · contact PI
The Shelf Live Evaluation of Investigational Dosage Forms$195,000
N02 · FY2012 · CA · contact PI
OTHER FUNCTIONS - ANALYSIS OF ANTI-CANCER CHEMICALS & PHARMACEUTICAL FORMULATION$74,000
N02 · FY2012 · CA · contact PI
Analysis of Anti-Cancer Chemicals and Pharmaceutical Formulations$9,800
N02 · FY2012 · CA · contact PI
The Shelf Live Evaluation of Investigational Dosage Forms$560,000
N02 · FY2011 · CA · contact PI
Analysis of Anti-Cancer Chemicals and Pharmaceutical Formulations$67,687
N02 · FY2011 · CA · contact PI
Analysis of Anti-Cancer Chemicals and Pharmaceutical Formulations$1,340,000
N02 · FY2010 · CA · contact PI
The Shelf Live Evaluation of Investigational Dosage Forms$550,000
N02 · FY2010 · CA · contact PI